Innovative Medicines Initiative

About IMI

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safe medicines for patients.IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA. Read more

Ebola+ Programme

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. The Ebola+ programme exemplifies how such multi-faceted collaborative efforts can have a stronger impact than any single player could alone. IMI2 offers a unique opportunity to complement the ongoing European and international efforts against Ebola.

Read more

From Twitter

We're looking towards a #healthierfuture for #cardiovascular #health https://t.co/UFumAcAtVt #health #outcomes https://t.co/479vsZBR3G about 13 hours ago by EFPIA
In this week's newsletter: #EHFG2016, #healthierfuture, & our PR on a new report on #counterfeit #medicines… https://t.co/izkPimEt5r about 13 hours ago by EFPIA